Previous 10 | Next 10 |
2024-01-02 16:31:09 ET More on Longboard Pharmaceuticals Longboard stock soars 132% in premarket trading on positive data Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals Historical earnings data for Longboard Pharmaceuticals Financial informa...
2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...
2024-01-02 10:09:39 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Soligenix Inc (NASDAQ: ...
2024-01-02 08:58:56 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Longboard Pharmaceuticals Inc (NASDAQ: LBPH) reported, this morning, that it’s rapidly moving forward with preparations for its global Phase 3 program, after achieving positive topline data from the PAC...
2024-01-02 08:46:54 ET More on Longboard Pharmaceuticals Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals Historical earnings data for Longboard Pharmaceuticals Financial information for Longboard Pharmaceuticals For further details see: L...
Bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures compared to 20.8% in the placebo group across the DEE study population A median seizure reduction of 72.1% in Dravet Syndrome (DS), 48.1% in Lennox-Gastaut Syndrome (LGS) and 61.2% in DEE Other was achiev...
• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET (5:30am PT) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced...
Initiated Single-Ascending Dose (SAD) Phase 1 clinical study evaluating LP659 Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the initiation ...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to one new employee. The Compensation Committee of the Board of Directors of...
2023-11-03 01:17:55 ET More on Longboard Pharmaceuticals Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals Historical earnings data for Longboard Pharmaceuticals Financial information for Longboard Pharmaceuticals For further details see: L...
News, Short Squeeze, Breakout and More Instantly...
Longboard Pharmaceuticals Inc. Company Name:
LBPH Stock Symbol:
NASDAQ Market:
Longboard Pharmaceuticals Inc. Website:
2024-07-16 13:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 15:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 10:45:05 ET Ford Motor Co. (F) F is trading UP for the last 5 days, and it at trading at $12.82 with volume of 15,047,573 and a one day change of $0.06 (0.47%). Ford Motor Co. has a 52-week low of 9.63 and a 52-week high of $15.42. The business's 50-day moving average pri...